KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $112,000 | -81.1% | 622 | -89.1% | 0.00% | -100.0% |
| Q2 2017 | $594,000 | +2600.0% | 5,729 | +1953.4% | 0.00% | – |
| Q1 2017 | $22,000 | -86.8% | 279 | -92.5% | 0.00% | -100.0% |
| Q4 2016 | $167,000 | -50.0% | 3,737 | -37.7% | 0.00% | -50.0% |
| Q3 2016 | $334,000 | +45.2% | 5,995 | +30.0% | 0.00% | +100.0% |
| Q2 2016 | $230,000 | -34.8% | 4,610 | -40.1% | 0.00% | -50.0% |
| Q1 2016 | $353,000 | +33.7% | 7,700 | +80.1% | 0.00% | 0.0% |
| Q4 2015 | $264,000 | -84.2% | 4,276 | -85.7% | 0.00% | -86.7% |
| Q3 2015 | $1,669,000 | +102.1% | 29,988 | +121.4% | 0.02% | +114.3% |
| Q2 2015 | $826,000 | +43.4% | 13,542 | +35.4% | 0.01% | +40.0% |
| Q1 2015 | $576,000 | +159.5% | 10,000 | +159.3% | 0.01% | +150.0% |
| Q4 2014 | $222,000 | – | 3,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|